Pune, India -- (SBWire) -- 05/07/2020 --Infinium Global Research has recently published a global report on "Hemato Oncology Testing Market (Products & Services - Assay Kits, and Services; Cancer - Leukemia, Non-hodgkin Lymphoma, and Other Cancers; Technology - PCR, NGS, IHC, and Other Technologies; End-user - Clinical Laboratories, Hospitals, and Other End-users): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025."
To Know More Request Sample of this Report@ https://www.infiniumglobalresearch.com/reports/sample-request/15251
Rising Cases of Hematologic Cancer is Driving the Growth
The rising cases of hematologic cancer is driving the growth of the hemato oncology testing market. The increasing awareness about personalized medicines contributes to the growth of the hemato oncology testing market. The rising number of collaborations to develop new assays promotes the growth of the hemato oncology testing market.
The growing geriatric population worldwide propels the growth of the hemato oncology testing market. On the flip side, uncertain reimbursement scenarios in various regions hamper the growth of the hemato oncology testing market. Nonetheless, research and development in hemato oncology testing create growth opportunities for the hemato oncology testing market.
"We are Now Including the Impact Analysis of the COVID-19 on this Premium Report and the Forecast Period of this Report Shall be Revised to 2020-2026. The Section on the Impact of COVID-19 on Hemato Oncology Testing Market is Included in the Report for Free."
North America is Anticipated to Dominate Share
Geographically, the global hemato oncology testing market is divided into North America, Asia-Pacific, Europe, and the Rest of the World. North America is anticipated to dominate the global hemato oncology testing market. The rising adoption of advanced treatment technologies and products in North America contributes to the growth of the hemato oncology testing market in North America.
Asia-Pacific region is expected to grow in the global hemato oncology testing market with a healthy CAGR over the forecast period. The large patient population present in the Asia-Pacific region stimulates the growth of the hemato oncology testing market in the Asia-Pacific region. Europe is growing in the global hemato oncology testing market.
Get this Section as a Free Customization in the Report Along With 30% Discount on the Study. https://www.infiniumglobalresearch.com/reports/customization/15251
"We Have Decided to Extend Our Support to the Industry on Account of Corona Outbreak by Offering Flat Discount 30% on All Our Studies and Evaluation of the Market Dynamics in Hemato Oncology Testing Amidst COVID-19"
Hemato Oncology Testing Market Coverage
Chapter - 1 Preface
=> Report Description
=> Research Methods
=> Research Approaches
Chapter - 2 Executive Summary
=> Hemato Oncology Testing Market Highlights
=> Hemato Oncology Testing Market Projection
=> Hemato Oncology Testing Market Regional Highlights
Chapter - 3 Global Hemato Oncology Testing Market Overview
=> Introduction
=> Market Dynamics
=> Porter's Five Forces Analysis
=> IGR-Growth Matrix Analysis
=> Value Chain Analysis of Hemato Oncology Testing Market
Chapter - 4 Hemato Oncology Testing Market Macro Indicator Analysis
Chapter - 5 Global Hemato Oncology Testing Market by Products & Services
=> Assay Kits
=> Services
Chapter - 6 Global Hemato Oncology Testing Market by Cancer
=> Leukemia
=> Non-hodgkin Lymphoma
=> Other Cancers
Chapter - 7 Global Hemato Oncology Testing Market by Technology
=> PCR
=> NGS
=> IHC
=> Other Technologies
Chapter - 8 Global Hemato Oncology Testing Market by End-user
=> Clinical Laboratories
=> Hospitals
=> Other End-users
Chapter - 9 Global Hemato Oncology Testing Market by Region 2019-2025
=> North America
=> Asia-Pacific
=> RoW
Chapter - 10 Company Profiles and Competitive Landscape
=> Abbott Laboratories
=> Thermo Fisher Scientific, Inc.
=> Illumina, Inc.
=> F. Hoffman-La Roche AG
=> QIAGEN NV
=> Arup Laboratories Inc.
=> Bio-Rad Laboratories, Inc.
=> ArcherDx, Inc.
=> Asuragen, Inc.
=> Invivoscribe Technologies, Inc.
=> Other Companies
Chapter - 11 Appendix
=> Primary Research Findings and Questionnaire
Browse Complete Report@ https://www.infiniumglobalresearch.com/healthcare-medical-devices/global-hemato-oncology-testing-market
About Infinium Global Research
Infinium Global Research is a business consulting and market research firm; a group of experts that caters to fulfilling business and market research needs of leading companies in various industry verticals and business segments. The company also serves government bodies, institutes and non-profit/non-government organizations to meet their knowledge and information needs.
Through our information services and solutions, we assist our clients to improve their performance and assess the market conditions to achieve their organizational goals. Our team of experts and analysts are engaged in continuously monitoring and assessing the market conditions to provide knowledge support to our clients. To help our clients and to stay updated with the advances and inventions in technology, business processes, regulations and environment, Infinium often conducts regular meets with industry experts and opinion leaders. Our key opinion leaders are involved in monitoring and assessing the progress in the business environment, so as to offer the best opinion to our clients.
